Publication:
In vitro treatments for the theront stage of the ciliate protozoan Cryptocaryon irritans

dc.contributor.authorPicón-Camacho, S.M.
dc.contributor.authorRuiz de Ybáñez, M.R.
dc.contributor.authorHolzer, A.S.
dc.contributor.authorArizcun Arizcun, M.
dc.contributor.authorMuñoz, P.
dc.contributor.departmentSanidad Animal
dc.date.accessioned2024-03-06T13:12:46Z
dc.date.available2024-03-06T13:12:46Z
dc.date.issued2011-04-06
dc.description© Inter-Research 2011 This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This document is the Published, version of a published work that appeared in final form in Diseases of Aquatics Organisms. To access the final edited and published work see doi: https://doi.org/10.3354/dao02315es
dc.description.abstractThe ciliate protozoan Cryptocaryon irritans Brown, 1951, the ‘marine white spot’, causes one of the most important parasitic fish diseases, with extensive losses every year in mariculture and in the ornamental fish industry. In the present study, we explore the in vitro use of 8 different com- pounds against the theront (infective) stage of C. irritans ; these compounds include extracts of natural products (epigallocatechin gallate (EGCG), L-DOPA, papain), peracetic acid-based compounds (Proxitane® 5:23 and 15% peracetic acid, PAA), quinine-based compounds (quinacrine hydrochloride and chloroquine diphosphate) and hydrogen peroxide. All of these compounds had an effect on theront survival; however, only EGCG caused significant theront mortality when applied in doses≥50 mg l–1 and over a period of 3 h; papain caused a maximum theront mortality of < 50%. We discuss the type of application and potential utility of the compounds tested as part of a management control strategy for C. irritans infections in marine aquaculture and the ornamental fish industry.es
dc.formatapplication/pdfes
dc.format.extent6es
dc.identifier.doihttps://doi.org/10.3354/dao02315
dc.identifier.eisbnDiseases of Aquatics Organisms. Vol. 94: 167–172, 2011es
dc.identifier.issnPrint: 0177-5103
dc.identifier.issnElectronic: 1616-1580
dc.identifier.urihttp://hdl.handle.net/10201/139987
dc.languageenges
dc.publisherInter-Research Science Publisheres
dc.relationSin financiación externa a la Universidades
dc.relation.publisherversionhttps://www.int-res.com/abstracts/dao/v94/n2/p167-172/es
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectMarine white spotes
dc.subjectChemotherapyes
dc.subjectEpigallocatechin gallatees
dc.subjectPeracetic acides
dc.subjectQuininees
dc.subjectFishes
dc.subjectParasitees
dc.titleIn vitro treatments for the theront stage of the ciliate protozoan Cryptocaryon irritanses
dc.typeinfo:eu-repo/semantics/articlees
dspace.entity.typePublicationes
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
In vitro treatments for the theront stage.pdf
Size:
101.25 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.26 KB
Format:
Item-specific license agreed upon to submission
Description: